Thilo Zander

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 377 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +9

A Patient with Lung Adenocarcinoma and RET Fusion Treated with Vandetanib

Oliver Gautschi, Thilo Zander, Franziska Aebersold Keller et al. · Journal of Thoracic Oncology · 2013 · 101 citations

Surgical Oncology, Ret Fusion Treated, Medicine +11

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Emanuele Zucca, Stéphanie Rondeau, Anna Vanazzi et al. · Blood · 2019 · 58 citations · Full text

Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials

Silvia Höfer, Katarzyna Elandt, Richard Greil et al. · Acta Oncologica · 2011 · 45 citations · Full text

BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients

Stefanie Gilli, Urban Novak, Behrouz Mansouri Taleghani et al. · Annals of Hematology · 2016 · 41 citations · Full text

Lymphoid Neoplasia, Cell Therapy, Transplantation +9